Literature DB >> 21755569

Temporal and within practice variability in the health improvement network.

Kevin Haynes1, Warren B Bilker, Tom R Tenhave, Brian L Strom, James D Lewis.   

Abstract

BACKGROUND: The Health Improvement Network (THIN) database is a primary care electronic medical record database in the UK designed for pharmacoepidemiologic research. Matching on practice and calendar year often is used to account for secular trends in time and differences across practices. However, little is known about the consistency within practices across observation years and among practices within a given year, in THIN or other large medical record databases.
METHODS: We analyzed mortality rates, cancer incidence rates, prescribing rates, and encounter rates across 415 practices from 2000 to 2007 using a practice-year as the unit of observation in separate random and fixed effects longitudinal Poisson regression models. Adjusted models accounted for aggregate practice-level characteristics (smoking, obesity, age, and Vision software experience).
RESULTS: In adjusted models, subsequent calendar years were associated with lower reported mortality rates, increasing cancer reporting rates, increasing prescriptions per patient, and decreasing encounters per patient, with a corresponding linear trend (p < 0.001 for all analyses). For calendar year 2007, the ratio of the 75th percentile to the 25th percentile for crude rate of cancer, mortality, prescriptions, and encounters was 1.63, 1.63, 1.45, and 1.42, respectively. Adjusting for practice characteristics reduced the among-practice variation by approximately 40%.
CONCLUSIONS: THIN data are characterized by secular trends and among-practice variation, both of which should be considered in the design of pharmacoepidemiology studies. Whether these are trends in data quality or true secular trends could not be definitively differentiated.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21755569      PMCID: PMC3225918          DOI: 10.1002/pds.2191

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  26 in total

1.  Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey.

Authors:  James D Lewis; Colleen Brensinger
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-07       Impact factor: 2.890

2.  Feasibility study and methodology to create a quality-evaluated database of primary care data.

Authors:  Alison Bourke; Hassy Dattani; Michael Robinson
Journal:  Inform Prim Care       Date:  2004

3.  The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey.

Authors:  N Britten; O Ukoumunne
Journal:  BMJ       Date:  1997-12-06

4.  Case-mix and variation in specialist referrals in general practice.

Authors:  Caoimhe O Sullivan; Rumana Z Omar; Gareth Ambler; Azeem Majeed
Journal:  Br J Gen Pract       Date:  2005-07       Impact factor: 5.386

5.  The relationship between time since registration and measured incidence rates in the General Practice Research Database.

Authors:  James D Lewis; Warren B Bilker; Rachel B Weinstein; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-07       Impact factor: 2.890

6.  Quality and variability of osteoporosis data in general practice computer records: implications for disease registers.

Authors:  S de Lusignan; T Chan; O Wood; N Hague; T Valentin; J Van Vlymen
Journal:  Public Health       Date:  2005-09       Impact factor: 2.427

7.  Issues in multiple imputation of missing data for large general practice clinical databases.

Authors:  Louise Marston; James R Carpenter; Kate R Walters; Richard W Morris; Irwin Nazareth; Irene Petersen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

8.  Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.

Authors:  M Ashworth; D Lloyd; R S Smith; A Wagner; G Rowlands
Journal:  J Public Health (Oxf)       Date:  2006-10-27       Impact factor: 2.341

9.  Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.

Authors:  C Watkins; I Harvey; P Carthy; L Moore; E Robinson; R Brawn
Journal:  Qual Saf Health Care       Date:  2003-02

10.  Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001.

Authors:  Arlene M Gallagher; Janice M Thomas; William T Hamilton; Peter D White
Journal:  J R Soc Med       Date:  2004-12       Impact factor: 18.000

View more
  13 in total

1.  Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.

Authors:  K A Forde; K Haynes; A B Troxel; S Trooskin; M T Osterman; S E Kimmel; J D Lewis; V Lo Re
Journal:  J Viral Hepat       Date:  2011-11-13       Impact factor: 3.728

2.  The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.

Authors:  Alexis Ogdie; Lauren Harter; Daniel Shin; Joshua Baker; Junko Takeshita; Hyon K Choi; Thorvardur Jon Love; Joel M Gelfand
Journal:  Ann Rheum Dis       Date:  2017-01-16       Impact factor: 19.103

3.  Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation.

Authors:  Charlene M Fares; Timothy J Williamson; Matthew K Theisen; Amy Cummings; Krikor Bornazyan; James Carroll; Marshall L Spiegel; Annette L Stanton; Edward B Garon
Journal:  JCO Clin Cancer Inform       Date:  2018-12

4.  Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices.

Authors:  Nicole Fett; Kevin Haynes; Kathleen Joy Propert; David J Margolis
Journal:  J Am Acad Dermatol       Date:  2014-01-28       Impact factor: 11.527

5.  Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.

Authors:  Alexis Ogdie; YiDing Yu; Kevin Haynes; Thorvardur Jon Love; Samantha Maliha; Yihui Jiang; Andrea B Troxel; Sean Hennessy; Steven E Kimmel; David J Margolis; Hyon Choi; Nehal N Mehta; Joel M Gelfand
Journal:  Ann Rheum Dis       Date:  2014-10-28       Impact factor: 19.103

6.  Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study.

Authors:  Alexis Ogdie; Kevin Haynes; Andrea B Troxel; Thorvardur Jon Love; Sean Hennessy; Hyon Choi; Joel M Gelfand
Journal:  Ann Rheum Dis       Date:  2012-12-21       Impact factor: 19.103

7.  Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.

Authors:  Alexis Ogdie; Sungat K Grewal; Megan H Noe; Daniel B Shin; Junko Takeshita; Zelma C Chiesa Fuxench; Rotonya M Carr; Joel M Gelfand
Journal:  J Invest Dermatol       Date:  2017-11-02       Impact factor: 8.551

Review 8.  Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research.

Authors:  Nicole Gray Weiskopf; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2012-06-25       Impact factor: 4.497

9.  The distribution of lung cancer across sectors of society in the United Kingdom: a study using national primary care data.

Authors:  Barbara Iyen-Omofoman; Richard B Hubbard; Chris J P Smith; Emily Sparks; Emma Bradley; Alison Bourke; Laila J Tata
Journal:  BMC Public Health       Date:  2011-11-10       Impact factor: 3.295

10.  Antihyperglycaemic treatment patterns, observed glycaemic control and determinants of treatment change among patients with type 2 diabetes in the United Kingdom primary care: a retrospective cohort study.

Authors:  Andrew Maguire; Beth D Mitchell; Javier Cid Ruzafa
Journal:  BMC Endocr Disord       Date:  2014-08-27       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.